Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jim Cramer - Mad Money
Intellia TherapeuticsNTLACOMMENTJun 28, 2021
Announced positive early results in gene-editing that would treat a rare genetic disease that impacts 50,000 people. Shares shot up 50% today. Regeneron is their partner. Cathy Wood heavily invests in these stocks.
Jim Cramer - Mad MoneyUnknown
$133.43
Stock price when the opinion was issued
$15.62
As of Jun 18, 2026. Market Open.
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
